# Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - Inspection Records

Source: https://www.keypedia.com/companies/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/02eeb237-fdd8-40a0-b45c-d4d88f49eb6c

> Inspection records and compliance data for Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) in Lianyungang, None. Access full analysis and detailed observations.

---

## Details

- Name: Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)
- FEI Number: 3007373503
- City: Lianyungang
- State: None
- Country Name: China
- Address Line 1: Dev. Zone, Economic & Technological; 38 Huanghe Avenue
- Zip Code: None
- Facility Type: Finished Drug Manufacturer
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - 2026-07-16](https://www.keypedia.com/records/483/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/dcfc67cd-7925-46e3-aa1d-6a3ada69852e) — source: FDA, date: July 16, 2026
- [FDA Inspection 1332762 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - 2026-07-16](https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/03e54d83-81a4-47c9-a464-0bc4a127e10f) — source: FDA, date: July 16, 2026
- [483 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - 2024-01-16](https://www.keypedia.com/records/483/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/f1c77da3-4ebf-4928-83f6-164ebfa4bbe0) — source: FDA, date: January 16, 2024
- [483 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - 2024-01-16](https://www.keypedia.com/records/483/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/9c7f1a0b-501b-4a40-b8eb-2b6869ca0071) — source: FDA, date: January 16, 2024
- [FDA Inspection 1229376 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - 2024-01-16](https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/f1c96fc4-5f91-4483-a675-8da44b8a6bf0) — classification: Official Action Indicated (OAI), source: FDA, date: January 16, 2024
- [FDA Inspection 1053612 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - 2018-05-14](https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/b62384b9-d50a-4580-8255-c771cb3e377f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 14, 2018
- [FDA Inspection 998184 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - 2016-11-02](https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/10253ad0-84b1-4d6e-b5a7-ad628e90d340) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 2, 2016
- [FDA Inspection 880301 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - 2014-05-13](https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/17ba8353-16dc-466c-9a2c-b6a5425bf9ce) — classification: No Action Indicated (NAI), source: FDA, date: May 13, 2014
- [FDA Inspection 793735 - Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site) - 2012-07-26](https://www.keypedia.com/records/fda_inspections/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/4e489853-8607-488d-80bd-535c60a0682b) — classification: No Action Indicated (NAI), source: FDA, date: July 26, 2012

## Related Companies

- [Aspen SA Sterile Operations (Pty) Ltd.](https://www.keypedia.com/companies/aspen-sa-sterile-operations-pty-ltd/b4918ce4-3b81-4fb7-bd04-2e1110728456)
- [Ningbo Shuangcheng Pharmaceutical Co., Ltd](https://www.keypedia.com/companies/ningbo-shuangcheng-pharmaceutical-co-ltd/942c1651-ee36-4163-9687-ca694ddc24d2)
- [Terumo BCT Vietnam Co. Ltd.](https://www.keypedia.com/companies/terumo-bct-vietnam-co-ltd/525a9500-4e19-460d-a654-9385db8249fd)
- [GlaxoSmithKline Biologicals SA](https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/9a234513-4162-49b8-b149-5c1be5aa9090)
- [Gland Chemical Private Limited](https://www.keypedia.com/companies/gland-chemical-private-limited/a9851b78-88de-4303-8a8b-7793507fdbde)
- [ENDO USA, Inc.](https://www.keypedia.com/companies/endo-usa-inc/f2df2e47-8303-4a2c-9881-5e2ecef64f22)
- [CareFusion 213, LLC](https://www.keypedia.com/companies/carefusion-213-llc/a1fedbce-120c-4b06-8def-c5a653db579a)
- [ENDO Pharmaceuticals Solutions, Inc.](https://www.keypedia.com/companies/endo-pharmaceuticals-solutions-inc/73c5da1a-04ad-4b56-9fae-f0a1371df51f)
- [Kaysersberg Pharmaceuticals SAS](https://www.keypedia.com/companies/kaysersberg-pharmaceuticals-sas/4f0bba88-dadd-49db-8e17-08165e705377)
- [Baxter Healthcare Corporation](https://www.keypedia.com/companies/baxter-healthcare-corporation/738590ab-c241-4de1-aaec-722e154bfc45)

## Related Officers

- [Qiao Y. Bobo](https://www.keypedia.com/people/qiao-y-bobo/c57c1128-9181-4c2a-81f9-cb9a171ece38)
- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
- [Investigator](https://www.keypedia.com/people/marvin-d-jones/3101a8da-f5c1-4e0c-b4b1-b09be181be36)
- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)